img

Global Pharmaceutical Excipients for Non-injection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pharmaceutical Excipients for Non-injection Market Research Report 2024

Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.
According to MRAResearch’s new survey, global Pharmaceutical Excipients for Non-injection market is projected to reach US$ 8997.9 million in 2033, increasing from US$ 4682 million in 2022, with the CAGR of 9.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Excipients for Non-injection market research.
Key manufacturers engaged in the Pharmaceutical Excipients for Non-injection industry include Dow, Nippon Fine Chemical, Nanjing Well Pharmaceutical, Jiangsu Maxim Biological, NOF, Croda, Jiangsu Poly Pharmaceutical, Er Kang Pharmaceutical and Guangzhou Hanfang Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pharmaceutical Excipients for Non-injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pharmaceutical Excipients for Non-injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pharmaceutical Excipients for Non-injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Dow
Nippon Fine Chemical
Nanjing Well Pharmaceutical
Jiangsu Maxim Biological
NOF
Croda
Jiangsu Poly Pharmaceutical
Er Kang Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Pfanstiehl
Xi'an Libang Pharmaceutical
Zhejiang Tianyushan Medicinal Oil
Segment by Type
Binders
Disintegrants
Lubricants
Fillers
Others

Segment by Application


Tablets
Capsules
Oral Liquids
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pharmaceutical Excipients for Non-injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Pharmaceutical Excipients for Non-injection Market Overview
1.1 Product Overview and Scope of Pharmaceutical Excipients for Non-injection
1.2 Pharmaceutical Excipients for Non-injection Segment by Type
1.2.1 Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2023-2033)
1.2.2 Binders
1.2.3 Disintegrants
1.2.4 Lubricants
1.2.5 Fillers
1.2.6 Others
1.3 Pharmaceutical Excipients for Non-injection Segment by Application
1.3.1 Global Pharmaceutical Excipients for Non-injection Market Value by Application: (2023-2033)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Oral Liquids
1.3.5 Others
1.4 Global Pharmaceutical Excipients for Non-injection Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Excipients for Non-injection Revenue 2018-2033
1.4.2 Global Pharmaceutical Excipients for Non-injection Sales 2018-2033
1.4.3 Global Pharmaceutical Excipients for Non-injection Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 Pharmaceutical Excipients for Non-injection Market Competition by Manufacturers
2.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pharmaceutical Excipients for Non-injection Average Price by Manufacturers (2018-2023)
2.4 Global Pharmaceutical Excipients for Non-injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Product Type & Application
2.7 Pharmaceutical Excipients for Non-injection Market Competitive Situation and Trends
2.7.1 Pharmaceutical Excipients for Non-injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Excipients for Non-injection Players Market Share by Revenue
2.7.3 Global Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Excipients for Non-injection Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Excipients for Non-injection Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global Pharmaceutical Excipients for Non-injection Global Pharmaceutical Excipients for Non-injection Sales by Region: 2018-2033
3.2.1 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2018-2023
3.2.2 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2024-2033
3.3 Global Pharmaceutical Excipients for Non-injection Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2018-2033
3.3.1 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2018-2023
3.3.2 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2024-2033
3.4 North America Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Excipients for Non-injection Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America Pharmaceutical Excipients for Non-injection Sales by Country (2018-2033)
3.4.3 North America Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Excipients for Non-injection Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2033)
3.5.3 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Excipients for Non-injection Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Country (2018-2033)
3.6.3 Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Excipients for Non-injection Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2018-2033)
3.7.3 Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2033)
3.8.3 Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Excipients for Non-injection Sales by Type (2018-2033)
4.1.1 Global Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023)
4.1.2 Global Pharmaceutical Excipients for Non-injection Sales by Type (2024-2033)
4.1.3 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2033)
4.2 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2018-2033)
4.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2018-2023)
4.2.2 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2024-2033)
4.2.3 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2033)
4.3 Global Pharmaceutical Excipients for Non-injection Price by Type (2018-2033)
5 Segment by Application
5.1 Global Pharmaceutical Excipients for Non-injection Sales by Application (2018-2033)
5.1.1 Global Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023)
5.1.2 Global Pharmaceutical Excipients for Non-injection Sales by Application (2024-2033)
5.1.3 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2033)
5.2 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2018-2033)
5.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2018-2023)
5.2.2 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2024-2033)
5.2.3 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2018-2033)
5.3 Global Pharmaceutical Excipients for Non-injection Price by Application (2018-2033)
6 Key Companies Profiled
6.1 Dow
6.1.1 Dow Corporation Information
6.1.2 Dow Description and Business Overview
6.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Dow Pharmaceutical Excipients for Non-injection Product Portfolio
6.1.5 Dow Recent Developments/Updates
6.2 Nippon Fine Chemical
6.2.1 Nippon Fine Chemical Corporation Information
6.2.2 Nippon Fine Chemical Description and Business Overview
6.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolio
6.2.5 Nippon Fine Chemical Recent Developments/Updates
6.3 Nanjing Well Pharmaceutical
6.3.1 Nanjing Well Pharmaceutical Corporation Information
6.3.2 Nanjing Well Pharmaceutical Description and Business Overview
6.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.3.5 Nanjing Well Pharmaceutical Recent Developments/Updates
6.4 Jiangsu Maxim Biological
6.4.1 Jiangsu Maxim Biological Corporation Information
6.4.2 Jiangsu Maxim Biological Description and Business Overview
6.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolio
6.4.5 Jiangsu Maxim Biological Recent Developments/Updates
6.5 NOF
6.5.1 NOF Corporation Information
6.5.2 NOF Description and Business Overview
6.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NOF Pharmaceutical Excipients for Non-injection Product Portfolio
6.5.5 NOF Recent Developments/Updates
6.6 Croda
6.6.1 Croda Corporation Information
6.6.2 Croda Description and Business Overview
6.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Croda Pharmaceutical Excipients for Non-injection Product Portfolio
6.6.5 Croda Recent Developments/Updates
6.7 Jiangsu Poly Pharmaceutical
6.6.1 Jiangsu Poly Pharmaceutical Corporation Information
6.6.2 Jiangsu Poly Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.7.5 Jiangsu Poly Pharmaceutical Recent Developments/Updates
6.8 Er Kang Pharmaceutical
6.8.1 Er Kang Pharmaceutical Corporation Information
6.8.2 Er Kang Pharmaceutical Description and Business Overview
6.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.8.5 Er Kang Pharmaceutical Recent Developments/Updates
6.9 Guangzhou Hanfang Pharmaceutical
6.9.1 Guangzhou Hanfang Pharmaceutical Corporation Information
6.9.2 Guangzhou Hanfang Pharmaceutical Description and Business Overview
6.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.9.5 Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
6.10 Pfanstiehl
6.10.1 Pfanstiehl Corporation Information
6.10.2 Pfanstiehl Description and Business Overview
6.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolio
6.10.5 Pfanstiehl Recent Developments/Updates
6.11 Xi'an Libang Pharmaceutical
6.11.1 Xi'an Libang Pharmaceutical Corporation Information
6.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Description and Business Overview
6.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.11.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Tianyushan Medicinal Oil
6.12.1 Zhejiang Tianyushan Medicinal Oil Corporation Information
6.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Description and Business Overview
6.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolio
6.12.5 Zhejiang Tianyushan Medicinal Oil Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Excipients for Non-injection Industry Chain Analysis
7.2 Pharmaceutical Excipients for Non-injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Excipients for Non-injection Production Mode & Process
7.4 Pharmaceutical Excipients for Non-injection Sales and Marketing
7.4.1 Pharmaceutical Excipients for Non-injection Sales Channels
7.4.2 Pharmaceutical Excipients for Non-injection Distributors
7.5 Pharmaceutical Excipients for Non-injection Customers
8 Pharmaceutical Excipients for Non-injection Market Dynamics
8.1 Pharmaceutical Excipients for Non-injection Industry Trends
8.2 Pharmaceutical Excipients for Non-injection Market Drivers
8.3 Pharmaceutical Excipients for Non-injection Market Challenges
8.4 Pharmaceutical Excipients for Non-injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global Pharmaceutical Excipients for Non-injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pharmaceutical Excipients for Non-injection Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Pharmaceutical Excipients for Non-injection Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Pharmaceutical Excipients for Non-injection, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Product Type & Application
Table 12. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical Excipients for Non-injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients for Non-injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Excipients for Non-injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023) & (K Units)
Table 18. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2018-2023)
Table 19. Global Pharmaceutical Excipients for Non-injection Sales by Region (2024-2033) & (K Units)
Table 20. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2024-2033)
Table 21. Global Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2018-2023)
Table 23. Global Pharmaceutical Excipients for Non-injection Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2024-2033)
Table 25. North America Pharmaceutical Excipients for Non-injection Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units)
Table 27. North America Pharmaceutical Excipients for Non-injection Sales by Country (2024-2033) & (K Units)
Table 28. North America Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Pharmaceutical Excipients for Non-injection Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe Pharmaceutical Excipients for Non-injection Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units)
Table 32. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2024-2033) & (K Units)
Table 33. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2024-2033) & (K Units)
Table 38. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2024-2033) & (K Units)
Table 43. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2024-2033) & (K Units)
Table 48. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2018-2023)
Table 51. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2024-2033)
Table 52. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023)
Table 53. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2024-2033)
Table 54. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Type (2024-2033)
Table 56. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2023)
Table 57. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2024-2033)
Table 58. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2018-2023)
Table 59. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2024-2033)
Table 60. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2018-2023)
Table 61. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2024-2033)
Table 62. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023)
Table 63. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2024-2033)
Table 64. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Application (2024-2033)
Table 66. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2018-2023)
Table 67. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2024-2033)
Table 68. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2018-2023)
Table 69. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2024-2033)
Table 70. Dow Corporation Information
Table 71. Dow Description and Business Overview
Table 72. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Dow Pharmaceutical Excipients for Non-injection Product
Table 74. Dow Recent Developments/Updates
Table 75. Nippon Fine Chemical Corporation Information
Table 76. Nippon Fine Chemical Description and Business Overview
Table 77. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product
Table 79. Nippon Fine Chemical Recent Developments/Updates
Table 80. Nanjing Well Pharmaceutical Corporation Information
Table 81. Nanjing Well Pharmaceutical Description and Business Overview
Table 82. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 84. Nanjing Well Pharmaceutical Recent Developments/Updates
Table 85. Jiangsu Maxim Biological Corporation Information
Table 86. Jiangsu Maxim Biological Description and Business Overview
Table 87. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product
Table 89. Jiangsu Maxim Biological Recent Developments/Updates
Table 90. NOF Corporation Information
Table 91. NOF Description and Business Overview
Table 92. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. NOF Pharmaceutical Excipients for Non-injection Product
Table 94. NOF Recent Developments/Updates
Table 95. Croda Corporation Information
Table 96. Croda Description and Business Overview
Table 97. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Croda Pharmaceutical Excipients for Non-injection Product
Table 99. Croda Recent Developments/Updates
Table 100. Jiangsu Poly Pharmaceutical Corporation Information
Table 101. Jiangsu Poly Pharmaceutical Description and Business Overview
Table 102. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 104. Jiangsu Poly Pharmaceutical Recent Developments/Updates
Table 105. Er Kang Pharmaceutical Corporation Information
Table 106. Er Kang Pharmaceutical Description and Business Overview
Table 107. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 109. Er Kang Pharmaceutical Recent Developments/Updates
Table 110. Guangzhou Hanfang Pharmaceutical Corporation Information
Table 111. Guangzhou Hanfang Pharmaceutical Description and Business Overview
Table 112. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 114. Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
Table 115. Pfanstiehl Corporation Information
Table 116. Pfanstiehl Description and Business Overview
Table 117. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Pfanstiehl Pharmaceutical Excipients for Non-injection Product
Table 119. Pfanstiehl Recent Developments/Updates
Table 120. Xi'an Libang Pharmaceutical Corporation Information
Table 121. Xi'an Libang Pharmaceutical Description and Business Overview
Table 122. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 124. Xi'an Libang Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Tianyushan Medicinal Oil Corporation Information
Table 126. Zhejiang Tianyushan Medicinal Oil Description and Business Overview
Table 127. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product
Table 129. Zhejiang Tianyushan Medicinal Oil Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Pharmaceutical Excipients for Non-injection Distributors List
Table 133. Pharmaceutical Excipients for Non-injection Customers List
Table 134. Pharmaceutical Excipients for Non-injection Market Trends
Table 135. Pharmaceutical Excipients for Non-injection Market Drivers
Table 136. Pharmaceutical Excipients for Non-injection Market Challenges
Table 137. Pharmaceutical Excipients for Non-injection Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pharmaceutical Excipients for Non-injection
Figure 2. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global Pharmaceutical Excipients for Non-injection Market Share by Type in 2022 & 2033
Figure 4. Binders Product Picture
Figure 5. Disintegrants Product Picture
Figure 6. Lubricants Product Picture
Figure 7. Fillers Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Pharmaceutical Excipients for Non-injection Market Share by Application in 2022 & 2033
Figure 11. Tablets
Figure 12. Capsules
Figure 13. Oral Liquids
Figure 14. Others
Figure 15. Global Pharmaceutical Excipients for Non-injection Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Pharmaceutical Excipients for Non-injection Market Size (2018-2033) & (US$ Million)
Figure 17. Global Pharmaceutical Excipients for Non-injection Sales (2018-2033) & (K Units)
Figure 18. Global Pharmaceutical Excipients for Non-injection Average Price (US$/Unit) & (2018-2033)
Figure 19. Pharmaceutical Excipients for Non-injection Report Years Considered
Figure 20. Pharmaceutical Excipients for Non-injection Sales Share by Manufacturers in 2022
Figure 21. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Pharmaceutical Excipients for Non-injection Players: Market Share by Revenue in 2022
Figure 23. Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Pharmaceutical Excipients for Non-injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 25. North America Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2033)
Figure 26. North America Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2033)
Figure 27. United States Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 28. Canada Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 29. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2033)
Figure 30. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2033)
Figure 31. Germany Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. France Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 33. U.K. Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 34. Italy Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 35. Russia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 36. Asia Pacific Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2018-2033)
Figure 37. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2018-2033)
Figure 38. China Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. Japan Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. India Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. Australia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 45. Latin America Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2033)
Figure 46. Latin America Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2033)
Figure 47. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Argentina Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2033)
Figure 51. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2033)
Figure 52. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. UAE Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 55. Global Sales Market Share of Pharmaceutical Excipients for Non-injection by Type (2018-2033)
Figure 56. Global Revenue Market Share of Pharmaceutical Excipients for Non-injection by Type (2018-2033)
Figure 57. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2018-2033)
Figure 58. Global Sales Market Share of Pharmaceutical Excipients for Non-injection by Application (2018-2033)
Figure 59. Global Revenue Market Share of Pharmaceutical Excipients for Non-injection by Application (2018-2033)
Figure 60. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2018-2033)
Figure 61. Pharmaceutical Excipients for Non-injection Value Chain
Figure 62. Pharmaceutical Excipients for Non-injection Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed